Exploring the link between psychological distress and treatment outcomes in lung cancer patients
the Association of Psychological Distress in Patients With Advanced Lung Cancer Treated With Immunotherapy or Targeted Therapy
This study looks at how stress and emotional struggles affect the success of cancer treatments in people with advanced lung cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Shanghai Chest Hospital Academic / other |
| Drugs / interventions | immunotherapy |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT06218901 on ClinicalTrials.gov |
What this trial studies
This observational study investigates how psychological distress affects the efficacy and survival of anti-tumor therapies, including immunotherapy and targeted therapy, in patients with advanced lung cancer. It aims to understand the multi-faceted nature of psychological distress and its impact on coping with cancer and treatment. By analyzing the associations between psychological stress and treatment outcomes, the study seeks to identify potential ways to improve patient care and therapeutic effectiveness.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a histologically confirmed diagnosis of lung cancer.
Not a fit: Patients who are unwilling to participate in the clinical trial will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies that address psychological distress, enhancing the overall efficacy of cancer therapies for patients.
How similar studies have performed: While the approach of linking psychological distress to treatment outcomes is not novel, previous studies have shown varying degrees of success in understanding its impact on cancer therapies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Histologically proven diagnosis of lung cancer * 18 years of age or older * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Not willing to participate in this clinical trial
Where this trial is running
Shanghai, Shanghai Municipality
- Shanghai Chest Hospital — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Study coordinator: Xiaomin Niu
- Email: ar_tey@hotmail.com
- Phone: (86) 21 22200000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.